Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation Effects on Transpulmonary Pressure in ARDS
NCT03237806Completed
- Sponsor
- Southeast University
- Start
- May 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of midazolam in acute respiratory distress syndrome (ARDS), sponsored by Southeast University. Primary endpoint: Transpulmonary pressure at 15 minutes. Started May 2015; status: completed.
02
Drugs
midazolam
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT03237806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03237806.